잠시만 기다려 주세요. 로딩중입니다.

Understanding of sarcopenia: from definition to therapeutic strategies

Archives of Pharmacal Research 2021년 44권 9호 p.876 ~ 889
김지원, Kim Ryuni, 최혜림, 이상진, 배규운,
소속 상세정보
김지원 ( Kim Jee-Won ) - Sookmyung Women’s University College of Pharmacy
 ( Kim Ryuni ) - Sookmyung Women’s University College of Pharmacy
최혜림 ( Choi Hye-Rim ) - Sookmyung Women’s University College of Pharmacy
이상진 ( Lee Sang-Jin ) - AniMusCure Inc. Research Institute of Aging Related Diseases
배규운 ( Bae Gyu-Un ) - Sookmyung Women’s University College of Pharmacy

Abstract


Sarcopenia refers to the gradual loss of skeletal muscle mass and function along with aging and is a social burden due to growing healthcare cost associated with a super-aging society. Therefore, researchers have established guidelines and tests to diagnose sarcopenia. Several studies have been conducted actively to reveal the cause of sarcopenia and find an economic therapy to improve the quality of life in elderly individuals. Sarcopenia is caused by multiple factors such as reduced regenerative capacity, imbalance in protein turnover, alteration of fat and fibrotic composition in muscle, increased reactive oxygen species, dysfunction of mitochondria and increased inflammation. Based on these mechanisms, nonpharmacological and pharmacological strategies have been developed to prevent and treat sarcopenia. Although several studies are currently in progress, no treatment is available yet. This review presents the definition of sarcopenia and summarizes recent understanding on the detailed mechanisms, diagnostic criteria, and strategies for prevention and treatment.

키워드

Sarcopenia; Aging; Skeletal muscle; Satellite cell; Protein turnover

원문 및 링크아웃 정보

등재저널 정보